AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H1359-H1365, 2005. First published May 13, 2005; doi:10.1152/ajpheart.01010.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/4/H1359    most recent
01010.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiriazis, H.
Right arrow Articles by Kaye, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiriazis, H.
Right arrow Articles by Kaye, D. M.

Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation

Helen Kiriazis,1 Xiao-Jun Du,1 Xinheng Feng,1 Elodie Hotchkin,2 Tanneale Marshall,3 Samara Finch,3 Xiao-Ming Gao,1 Gavin Lambert,2 Julia K. Choate,4 and David M. Kaye3

1Experimental Cardiology Laboratory, 2Human Neurotransmitter Laboratory, and 3Wynn Department of Metabolic Cardiology, Baker Heart Research Institute, Melbourne; and 4Department of Physiology, Monash University, Melbourne, Australia

Submitted 4 October 2004 ; accepted in final form 9 May 2005

Cardiac-specific overexpression of nerve growth factor (NGF), a neurotrophin, leads to sympathetic hyperinnervation of heart. As a consequence, adverse functional changes that occur after chronically enhanced sympathoadrenergic stimulation of heart might develop in this model. However, NGF also facilitates synaptic transmission and norepinephrine uptake, effects that would be expected to restrain such deleterious outcomes. To test this, we examined 5- to 6-mo-old transgenic (TG) mice that overexpress NGF in heart and their wild-type (WT) littermates using echocardiography, invasive catheterization, histology, and catecholamine assays. In TG mice, hypertrophy of the right ventricle was evident (+67%), but the left ventricle was only mildly affected (+17%). Left ventricular (LV) fractional shortening and fractional area change values as indicated by echocardiography were similar between the two groups. Catheterization experiments revealed that LV ±dP/dt values were comparable between TG and WT mice and responded similarly upon isoproterenol stimulation, which indicates lack of {beta}-adrenergic receptor dysfunction. Although norepinephrine levels in TG LV tissue were approximately twofold those of WT tissue, TG plasma levels of the neuronal norepinephrine metabolite dihydroxyphenyglycol were fivefold those of WT plasma. A greater neuronal uptake activity was also observed in TG LV tissue. In conclusion, overexpression of NGF in heart leads to sympathetic hyperinnervation that is not associated with detrimental effects on LV performance and is likely due to concomitantly enhanced norepinephrine neuronal uptake.

echocardiography; myocardial contraction; catecholamine; transgenic; nerve growth factor



Address for reprint requests and other correspondence: D. M. Kaye, Wynn Dept. of Metabolic Cardiology, Baker Heart Research Institute, P.O. Box 6492 St. Kilda Road Central, Melbourne, Victoria 8008, Australia (E-mail: david.kaye{at}baker.edu.au)




This article has been cited by other articles:


Home page
Circ. Res.Home page
N. Feng, D. B. Hoover, and N. Paolocci
Forever Young?: Nerve Growth Factor, Sympathetic Fibers, and Right Ventricle Pressure Overload
Circ. Res., June 22, 2007; 100(12): 1670 - 1672.
[Full Text] [PDF]


Home page
HypertensionHome page
M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs
Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts
Hypertension, February 1, 2006; 47(2): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Esler and D. Kaye
Sympathetic Nervous System Neuroplasticity
Hypertension, February 1, 2006; 47(2): 143 - 144.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.